Focal facial dermal dysplasia
Focal Facial Dermal Dysplasia is a rare genetic disorder that affects the development of the facial dermis. It is characterized by bitemporal or preauricular skin lesions, apparent at birth or shortly thereafter. These lesions are typically hairless and scar-like, and may have associated pigmentation changes. Other features may include distichiasis (double row of eyelashes), partial or complete absence of the Meibomian glands, and/or absence of the lacrimal puncta.
Signs and Symptoms
The primary symptom of Focal Facial Dermal Dysplasia is the presence of bitemporal or preauricular skin lesions. These lesions are typically hairless and scar-like, and may have associated pigmentation changes. Other features may include distichiasis (double row of eyelashes), partial or complete absence of the Meibomian glands, and/or absence of the lacrimal puncta.
Causes
Focal Facial Dermal Dysplasia is a genetic disorder caused by mutations in the ADAM17 gene. This gene provides instructions for making a protein that is involved in the regulation of various cellular processes, including cell proliferation, cell differentiation, and apoptosis (programmed cell death).
Diagnosis
Diagnosis of Focal Facial Dermal Dysplasia is typically based on the clinical features and confirmed by genetic testing. Genetic testing can identify mutations in the ADAM17 gene, confirming the diagnosis.
Treatment
There is currently no cure for Focal Facial Dermal Dysplasia. Treatment is symptomatic and supportive, and may include surgical correction of the skin lesions and other associated features.
Prognosis
The prognosis for individuals with Focal Facial Dermal Dysplasia varies. The disorder does not typically affect lifespan, but the severity of symptoms can vary widely among affected individuals.
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


